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TRANSCRIPTION FACTOR HES1 MODULATES OSTEOARTHRITIS
DEVELOPMENT IN COOPERATION WITH CAMKII
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H. Akiyama z, S. Tanaka y, H. Kawaguchi y,x, T. Saito k,y. y Sensory and
Motor System Med., The Univ. of Tokyo, Tokyo, Japan; zOrthopedic
Surgery, Graduate Sch. of Med., Gifu Univ., Gifu, Japan; x Tokyo Kosei
Nenkin Hosp., Tokyo, Japan; kBone and Cartilage Regenerative Med.,
Faculty of Med., The Univ. of Tokyo, Tokyo, Japan
Purpose: We recently reported that the RBPj-dependent Notch sig-
naling in chondrocytes modulates endochondral ossiﬁcation and
osteoarthritis (OA) development. Since this signal was shown to be
mediated through induction of the target gene Hes1 in chondrocytes,
the present study investigated the role of Hes1 and the underlying
mechanism during OA development.
Methods: We generated tissue-speciﬁc knockout mice of Hes1 by
mating Sox9-Cre knock-in mice or tamoxifen-inducible Col2a1-Cre
transgenic mice (Col2a1-CreERT) with mice homozygous for a ﬂoxed
Hes1 allele (Hes1ﬂ/ﬂ). To analyze the role Hes1 in articular cartilage after
maturation, we injected tamoxifen into 7-week-old Col2a1-CreER-
T;Hes1ﬂ/ﬂ mice, and created a surgically induced OA model by resecting
the medial collateral ligament and the medial meniscus in the knee
joints one week after the injection. The OA severity was quantiﬁed by
the OARSI histopathology grade 8 weeks after the surgery. We exam-
ined transcriptional regulation by chromatin immunoprecipitation
(ChIP) sequencing using human chondrogenic SW1353 cells transfected
with the FLAG-tagged Hes1 construct, and conﬁrmed the trans-
activation by luciferase assay using HeLa cells transfected with the
reporter construct containing a promoter fragment of themarker genes.
For expression analyses, we performed immunoﬂuorescence and real-
time RT-PCR. For protein-protein interaction analyses, we performed
co-immunoprecipitation (Co-IP) assay in SW1353 cells. For functional
analyses, we used lentiviral doxycycline-inducible expression vectors in
mouse chondrogenic ATDC5 cells and examined the expression of tar-
get genes by real-time RT-PCR.
Results: Although the Sox9-Cre;Hes1ﬂ/ﬂmice died in the perinatal period,
the embryos exhibited normal sketetal growth. However, the OA
development was prevented in the Col2a1-CreERT;Hes1ﬂ/ﬂ knee joints
more than in the control Hes1ﬂ/ﬂ joints. OARSI grading conﬁrmed that
conditional knockout of Hes1 caused signiﬁcant resistance to cartilage
degradation. Immunoﬂuorescence revealed that Mmp13 and Adamts5
expressions were suppressed in the articular cartilage of Col2a1-CreERT
mice. ChIP sequencing showed the highest binding of Hes1 in intron 4 of
MMP13 and in intron 7 of ADAMTS5, and the luciferase assay conﬁrmed
thatHes1 stimulated the enhancer activities of these elements. Although
Hes1 is generally known to be a transcriptional repressor, the present
data suggest that Hes1 directly enhances Mmp13 and Adamts5 expres-
sions. To reveal the molecular mechanism underlying transcriptional
induction of these catabolic factors by Hes1, we focused on calcium/
calmodulin-dependent protein kinase II (CaMKII), which is the only
factor known to change Hes1 from transcriptional repressor to tran-
scriptional activator by phosphorylating it. Among subtypes of CaMKII,
the d form was most highly expressed in mouse articular chondrocytes.
Immunoﬂuorescence of the mouse experimental model revealed that
bothHes1 and active CaMKII were increased in articular cartilage during
OA progression. Co-IP conﬁrmed the binding of Hes1 and CaMKIId pro-
teins. When both these proteins were lentivirally co-overexpressed in
ATDC5 cells,Mmp13 and Adamts5 expressionswere inducedmorehighly
than a single overexpression of each gene. Furthermore, a mutagenesis
ofHes1 in the serine residueof CaMKII phosphorylation site caused a loss
of its ability to induce Mmp13 and Adamts5.
Conclusions: Hes1 modulates OA development through the trans-
activation of Mmp13 and Adamts5 through the phosphorylation by
CaMKIId. Notch/Rbpj and Hes1 pathways in cooperation with CaMKIId
may be possible therapeutic targets of OA.15
RECEIVING OPERATING CHARACTERISTICS ANALYSIS OF OUTCOMES
OF TOTAL JOINT REPLACEMENT FOR OSTEOARTHRITIS
A.M. Valdes, S. Doherty, G.S. Fernandes, W. Jenkins, M. Wheeler,
M. Doherty. Univ. of Nottingham, Nottingham, United Kingdom
Purpose: Persistent pain after joint replacement is a considerable
problem affecting between 7 and 20% of total knee replacement (TKR)
patients and 2-8% of total hip replacement (THR) patients. The aim of
the present study was to assess the factors that contribute to patient
satisfaction and mobility post joint replacement.
Methods: 735 knee and hip osteoarthritis patients were recruited from
orthopaedic clinics 1 year post total joint replacement and a research
nurse assessed their level of mobility, satisfaction with their surgery,
medical history, pain intensity, PainDETECT questionnaire scores,
quality of life and quality of sleep. Catastrophizing and illness behavior
were also available for a subset of patients.
Results: Among the 308 patients who had undergone THR, 98%
were very satisﬁed of the outcome of their surgery, 94% reported a
signiﬁcant pain improvement and 83% an improvement in their
ability to walk post THR, 3.9% had undergone a revision surgery. This
compared to 75% satisfaction in the 383 post TKR cases, 3.1% of
whom had a revision surgery, 85% reported a pain improvement and
72% an improvement in mobility. Among patients who had under-
gone both TKR and THR procedures satisfaction was 84%, 90%
reported a substantial pain improvement even though the rate of
revision surgery has much higher (13.6%)than among TKR only or
THR only cases. The factors that contributed to lack of satisfaction
post surgery in THR cases were the WOMAC pain score (OR¼.25 95%
CI 1.05-1.48 per Likert scale unit p<0.012) younger age (OR¼0.92
95%CI 0.86-0.99 per year p<0.018) and presence of revision surgery
(OR¼8.13 95%CI 1.4-46 p<0.018). Among post-TKR patients the
strongest factors contributing to lack of satisfaction were the
WOMAC pain score (OR¼1.15 95%CI 1.06-1.24 per Likert scale unit),
poor sleep (OR¼1.25 95%CI 1.04-1.49 in a scale 0-10) and presence of
possible neuropathic pain (as deﬁned by the PainDETECT ques-
tionnaire) (OR¼1.90 95%CI 1.03-3.49). Among patients with both TKR
and THR procedures the only signiﬁcant factor contributing to sat-
isfaction was the WOMAC stiffness score (OR¼3.39 95%CI 1.21-9.48
per Likert scale unit). An analysis in a subset of 163 post-TKR cases
on which catastrophizing measures were available revealed that,
although a high catastrophizing score is indeed associated with
satisfaction, this association was entirely mediated by pain and
dropped from the model after adjusting for WOMAC pain scores.
Using a receiver operating characteristics (ROC) analysis we found
that among TKR cases, age, sex and BMI provide no useful infor-
mation on patient satisfaction (area under the curve(AUC)¼0.496).
On the other hand the presence of possible neuropathic pain (NP)
alone achieved an AUC¼0.643 [95%CI 0.58 - 0.705] on patient
